Abiopharma

🔍 Gilfeather Michael J (Director)

Company: Orange County Bancorp, Inc. /DE/ (OBT)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 16,853 shares of Common Stock (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 126,200.00 | transaction_form_type: 4 | Footnotes: F4, F1
• Acquired 9,438 shares of Common Stock (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 135,638.00 | transaction_form_type: 4 | Footnotes: F5, F1
• Sold 6,189 shares of Common Stock at $31.15 per share (Direct)
  Date: 2026-03-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 129,449.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 200 shares of Common Stock at $31.2499 per share (Direct)
  Date: 2026-03-19 | Code: P | equity_swap_involved: 0 | shares_owned_after: 16,400.00 | transaction_form_type: 4
• Holds 26,460 shares of Phantom Stock (Derivative)
  Date: 2026-03-19 | Code: H | shares_owned_after: 26,460.00 | Footnotes: F6, F6, F6

Footnotes:

• F1: Includes restricted stock units which vest at a rate of 1/3 per year commencing on March 21, 2025.
• F2: Includes restricted stock units which vest at a rate of 1/3 per year commencing on March 20, 2026.
• F3: Includes restricted stock units which vest on December 31, 2026.
• F4: Restricted stock units which vest at a rate of 1/3 per year commencing on March 19, 2027.
• F5: Restricted stock units which vest on March 19, 2029.
• F6: Each share of phantom stock is the economic equivalent of one share of common stock and becomes payable upon the reporting person's separation of service as a director.